Duke Spinoff Cloud Pharmaceuticals Names Two Executives to Team

Drug discovery and development firm Cloud Pharmaceuticals named two new executives to its management team. New CFO Lyle Lohmeyer’s experience includes financial management positions at AAIPharma, Qualia Networks, and Energy Conversion Systems Holdings. Don Van Dyke joins as Cloud Pharmaceuticals’ COO after previously working as a consultant to the company. Research Triangle Park, NC-based Cloud Pharmaceuticals discovers and develops new drugs using proprietary technology originally developed at Duke University.


Frank Vinluan is an Xconomy editor based in Research Triangle Park. You can reach him at [email protected] Follow @frankvinluan

Trending on Xconomy